⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
XCF Global (NASDAQ:SAFX) Outlines Strategy to Scale, Integrate and Deliver Following Completion of Business Combination
accessnewswire.com
SAFX
Marengo Therapeutics Presents Phase 2 STARt-001 Results at ESMO 2026 Demonstrating Tissue-Agnostic Single-Agent Activity of Invikafusp Alfa in TMB-H Solid Tumors Mostly Unresponsive to Immune Checkpoint Blockade
prnewswire.com
VRTX
Hillman and FC Cincinnati Host Second Annual Trade School Discovery Day to Introduce Local Students to Skilled-Trade Careers
globenewswire.com
HLMN
Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026
globenewswire.com
RVMD
Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
globenewswire.com
NVS
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study
businesswire.com
TAK
Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study
businesswire.com
BMY
FNB Harvest d'actions à revenu élevé annonce les distributions d’octobre 2026
businesswire.com
LLY
AMZN
MSFT
NVDA
COIN
PLTR
TSLA
META
AMD
AVGO
COST
GOOGL
NFLX
AAPL
HOOD
SOFI
BKNG
CRWD
JNJ
ORCL
CME
ENB
SHOP
SU
TEL
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
Archrock Announces Timing for Third Quarter 2026 Results
globenewswire.com
AROC